More Southern California Physicians Embrace the MEDeMORPHUS Electronic Prescription Program.
SANTA ANA, Calif.--(BUSINESS WIRE)--Sept. 23, 2002
-- 250 new physicians join 2,500 who already use MEDeMORPHUS e-prescribing system to help improve safety, reduce prescription errors and increase convenience for patients -- Company's technology continues to capture market share in rapidly growing e-prescribing niche -- Technology reduces "hassle factor" for doctors and patients
MEDeMORPHUS Healthcare Solutions, a technology subsidiary of PacifiCare Health Systems, Inc. (Nasdaq:PHSY), announced that four more Southern California medical groups have licensed MEDeMORPHUS' wireless, point-of-care device to improve the accuracy and efficiency of prescribing medications for their patients.
The four medical groups - High Desert Medical Group in Lancaster, Harriman-Jones Medical Group in Long Beach, Bright Medical Group in Whittier and Riverside Medical Clinic in Riverside - will add approximately 250 physicians to MEDeMORPHUS' growing base of physicians now using its e-prescribing systems in seven states, bringing total subscribers to nearly 2,500.
"These four medical groups are committed to promoting an efficient system that provides better patient care by utilizing mobile technology that physicians need at the point of care," said David Grant, president and chief executive officer of MEDeMORPHUS. "We believe these new partnerships with leading Southern California medical groups represent a critical expansion for MEDeMORPHUS in the rapidly growing e-prescribing market."
The MEDeMORPHUS system is a wireless, point-of-care e-prescribing device that helps make the prescription process more efficient and less time-consuming and helps reduce the likelihood of medical errors. MEDeMORPHUS can also help enhance a physician group's revenue stream with simple timesaving measures and administrative efficiencies, allowing doctors to spend more time with patients. The system also can automate mail service enrollment, reduce prior authorization calls and helps ensure prescription compliance.
"With MEDeMORPHUS, our physicians will be able to increase the speed by which patients get their medications, improve care and increase patient satisfaction by eliminating the frustration and hassle factor traditionally involved," said William Stimmler, M.D., family practitioner and chairman of the board at Bright Medical Associates, Inc. "The MEDeMORPHUS technology can help our physicians select the recommended first-line drugs that are on a health plan's formulary, while overseeing drug-to-drug interaction. We believe the MEDeMORPHUS system will help our physicians provide better care for their patients."
"We believe e-prescribing will help improve the quality of care that we deliver," said Andrea De Coro, Pharm.D., director of Clinical Pharmacy Services at Harriman Jones Medical Group. "The MEDeMORPHUS handheld electronic prescribing system can help our physicians detect potential drug interactions, alert them to drug allergies and provide them with access to important drug information at the time of prescribing. We also anticipate that MEDeMORPHUS will help reduce prescription errors since prescriptions will be printed instead of handwritten."
"We selected MEDeMORPHUS because it has the support of health plans," said Charles Myaing Lim, M.D., medical director, High Desert Medical Group. "Pharmacy benefits are constantly changing. Now, physicians must keep track of what medications are covered according to the formulary and health plan coverage. The MEDeMORPHUS system will help automate this process, making it more efficient without compromising the care of the patient."
"MEDeMORPHUS was the right choice for us since we wanted to align ourselves with a progressive technology company to best serve our patients," said Dr. Ravi Berry, chairman of Information Technology for Riverside Medical Clinic. "Besides the prospect of saving us time and money, MEDeMORPHUS is also working on newer, more advanced modules that will include automated dictation and transcription services. These services will connect with the e-prescribing tool for a comprehensive solution that reduces administrative hassles and further streamlines the office workflow."
MEDeMORPHUS, formerly Rx-Connect, is a division of PacifiCare Health Systems, one of the nation's largest health and consumer services companies. The cornerstone of the company is a wireless, point-of-care device that reduces the time physicians, their staffs and patients often spend seeking access to and approval of pharmaceutical drugs, while reducing medical errors and managing escalating healthcare costs. MEDeMORPHUS' expansion plans include additional product offerings with the addition of new capabilities including dictation of patient notes, billing, clinical reference, and the ability to order services such as laboratory tests and medical equipment for home use. More than 2,500 physicians in seven states now use the system. For more information, contact Brandi Comi at 714-825-6724, or log on to www.medemorphus.com.
About PacifiCare Health Systems
PacifiCare Health Systems is one of the nation's largest health and consumer services companies with approximately $11 billion in annual revenues. Primary operations include managed care products for employer groups and Medicare beneficiaries in eight western states and Guam serving approximately 3.3 million members. Other specialty products and operations include pharmacy and medical management, behavioral health services, life and health insurance and dental and vision services. More information on PacifiCare can be obtained at www.pacificare.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Sep 23, 2002|
|Previous Article:||Fitch Upgrades Two Classes Of Merrill Lynch Series 1995-C3.|
|Next Article:||Fitch Rates Pasadena, Texas GO Bonds 'AA-'.|